German PMS trial (AWB) to evaluate therapy in reflux disease and NSAR-symptoms
Study identifier:1312004007
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
German PMS trial (AWB) to evaluate therapy in reflux disease and NSAR-symptoms
Medical condition
Gastroesophageal Reflux
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
67130
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Sept 2005
Primary Completion Date: -
Study Completion Date: 01 Dec 2005
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 patients with GERD or NSAID-related ulcers | - |
Contacts
Investigators
Principal Investigator
Kai Richter
AstraZeneca Medical Department
